Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery

Completed · Phase 1/Phase 2

Conditions studied: Colorectal Cancer

In brief

RATIONALE: Vaccines made from a patient's white blood cells and tumor cells may make the body build an immune response to kill tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining vaccine therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of vaccine therapy combined with leucovorin and fluorouracil in treating patients who have undergone surgery to completely remove stage II or stage III colon cancer.

Key facts

Study ID

NCT00016133

Run by

Intracel

Starts

2001-03-01

Expected to finish

2004-08-01

Last updated by the study team

2013-05-30

Who can join

Age: 21 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

• John and Dorothy Morgan Cancer Center at Lehigh Valley Hospital — Allentown, Pennsylvania, United States
• Inova Fairfax Hospital — Fairfax, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.